Overview

Pharmacokinetics and Pharmacodynamics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade

Status:
Active, not recruiting

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to illustrate pharmacokinetics and pharmacodynamics of sugammadex in reversal of vecuronium-induced neuromuscular blockade in anesthesia obese patients undergoing bariatric surgery.

Phase:

Phase 4

Details

Lead Sponsor:

Guangzhou General Hospital of Guangzhou Military Command

Treatments:

Vecuronium Bromide